We are live on ! Find out more
NVNO

enVVeno Medical
NVNO

20 hedge funds and large institutions have $9.21M invested in enVVeno Medical in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 4

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

0.11% less ownership

Funds ownership: 0.66% → 0.55% (-0.11%)

9% less funds holding

Funds holding: 22 → 20 (-2)

33% less capital invested

Capital invested by funds: $13.7M → $9.21M (-$4.51M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
20
Holders Change
-2
Holders Change %
-9.09%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
2
Increased
5
Reduced
4
Closed
2
Calls
$903K
Puts
–
Net Calls
+$903K
Net Calls Change
-$2.41M

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$220K
2
UOC
UBS O'Connor
Illinois
+$113K
3
Northern Trust
Northern Trust
Illinois
+$14.4K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$5.28K
5
EE
EWG Elevate
California
+$1.83K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$51.6K
2
Two Sigma Advisers
Two Sigma Advisers
New York
-$24.4K
3
Morgan Stanley
Morgan Stanley
New York
-$10.8K
4
UBS Group
UBS Group
Switzerland
-$9.75K
5
TRCT
Tower Research Capital (TRC)
New York
-$4.67K

NVNO Hedge Fund Activity: Q4 2022 in Review

20 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical (NVNO) for Q4 2022, worth a combined $9.21M — down 33% from $13.7M a quarter earlier.

Fund positioning in NVNO was balanced in Q4 2022: 2 funds opened new positions, 2 closed out, 5 added to existing stakes and 4 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $220K. The largest seller was Citadel Advisors, cutting an estimated $51.6K.

  • 20 institutional investors held enVVeno Medical (NVNO) as of Q4 2022, down from 22 in Q3 2022.
  • Funds reported $9.21M of enVVeno Medical stock for Q4 2022, down 33% quarter-over-quarter.
  • 2 funds opened new enVVeno Medical positions in Q4 2022 and 2 closed out, a net change of 0 holders.
  • The largest enVVeno Medical buyer in Q4 2022 was Susquehanna International Group, an estimated $220K added.
  • The largest enVVeno Medical seller in Q4 2022 was Citadel Advisors, an estimated $51.6K sold.

Based on aggregated 13F filings for Q4 2022.